Department of Anatomical Pathology, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
Department of Medical Research, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City 231, Taiwan.
Int J Mol Sci. 2021 Dec 10;22(24):13310. doi: 10.3390/ijms222413310.
The human host immune responses to parasitic infections are complex. They can be categorized into four immunological pathways mounted against four types of parasitic infections. For intracellular protozoa, the eradicable host immunological pathway is TH1 immunity involving macrophages (M1), interferon gamma (IFNγ) CD4 T cells, innate lymphoid cells 1 (NKp44+ ILC1), CD8 T cells (Effector-Memory4, EM4), invariant natural killer T cells 1 (iNKT1) cells, and immunoglobulin G3 (IgG3) B cells. For intracellular protozoa, the tolerable host immunological pathway is TH1-like immunity involving macrophages (M2), interferon gamma (IFNγ)/TGFβ CD4 T cells, innate lymphoid cells 1 (NKp44- ILC1), CD8 T cells (EM3), invariant natural killer T 1 (iNKT1) cells, and immunoglobulin A1 (IgA1) B cells. For free-living extracellular protozoa, the eradicable host immunological pathway is TH22 immunity involving neutrophils (N1), interleukin-22 CD4 T cells, innate lymphoid cells 3 (NCR+ ILC3), iNKT17 cells, and IgG2 B cells. For free-living extracellular protozoa, the tolerable host immunological pathway is TH17 immunity involving neutrophils (N2), interleukin-17 CD4 T cells, innate lymphoid cells 3 (NCR- ILC3), iNKT17 cells, and IgA2 B cells. For endoparasites (helminths), the eradicable host immunological pathway is TH2a immunity with inflammatory eosinophils (iEOS), interleukin-5/interleukin-4 CD4 T cells, interleukin-25 induced inflammatory innate lymphoid cells 2 (iILC2), tryptase-positive mast cells (MCt), iNKT2 cells, and IgG4 B cells. For ectoparasites (parasitic insects and arachnids), the eradicable host immunological pathway is TH2b immunity with inflammatory basophils, chymase- and tryptase-positive mast cells (MCct), interleukin-3/interleukin-4 CD4 T cells, interleukin-33 induced nature innate lymphoid cells 2 (nILC2), iNKT2 cells, and immunoglobulin E (IgE) B cells. The tolerable host immunity against ectoparasites and endoparasites is TH9 immunity with regulatory eosinophils, regulatory basophils, interleukin-9 mast cells (MMC9), thymic stromal lymphopoietin induced innate lymphoid cells 2, interleukin-9 CD4 T cells, iNKT2 cells, and IgA2 B cells. In addition, specific transcription factors important for specific immune responses were listed. This JAK/STAT signaling is key to controlling or inducing different immunological pathways. In sum, Tfh is related to STAT5β, and BCL6 expression. Treg is related to STAT5α, STAT5β, and FOXP3. TH1 immunity is related to STAT1α, STAT4, and T-bet. TH2a immunity is related to STAT6, STAT1α, GATA1, and GATA3. TH2b immunity is related to STAT6, STAT3, GATA2, and GATA3. TH22 immunity is associated with both STAT3α and AHR. THαβ immunity is related to STAT1α, STAT1β, STAT2, STAT3β, and ISGF. TH1-like immunity is related to STAT1α, STAT4, STAT5α, and STAT5β. TH9 immunity is related to STAT6, STAT5α, STAT5β, and PU.1. TH17 immunity is related to STAT3α, STAT5α, STAT5β, and RORG. TH3 immunity is related to STAT1α, STAT1β, STAT2, STAT3β, STAT5α, STAT5β, and ISGF. This categorization provides a complete framework of immunological pathways against four types of parasitic infections. This framework as well as relevant JAK/STAT signaling can provide useful knowledge to control allergic hypersensitivities and parasitic infections via development of vaccines or drugs in the near future.
人体宿主对寄生虫感染的免疫反应是复杂的。它们可以分为四种针对四种类型寄生虫感染的免疫途径。对于细胞内原生动物,可消除的宿主免疫途径是涉及巨噬细胞(M1)、干扰素γ(IFNγ)、CD4 T 细胞、先天淋巴细胞 1(NKp44+ ILC1)、CD8 T 细胞(效应记忆 4,EM4)、固有自然杀伤 T 细胞 1(iNKT1)细胞和免疫球蛋白 G3(IgG3)B 细胞的 TH1 免疫。对于细胞内原生动物,可耐受的宿主免疫途径是涉及巨噬细胞(M2)、干扰素γ(IFNγ)/TGFβ、CD4 T 细胞、先天淋巴细胞 1(NKp44- ILC1)、CD8 T 细胞(EM3)、固有自然杀伤 T 细胞 1(iNKT1)细胞和免疫球蛋白 A1(IgA1)B 细胞的 TH1 样免疫。对于自由生活的细胞外原生动物,可消除的宿主免疫途径是涉及中性粒细胞(N1)、白细胞介素 22(IL-22)、CD4 T 细胞、先天淋巴细胞 3(NCR+ ILC3)、iNKT17 细胞和 IgG2 B 细胞的 TH22 免疫。对于自由生活的细胞外原生动物,可耐受的宿主免疫途径是涉及中性粒细胞(N2)、白细胞介素 17(IL-17)、CD4 T 细胞、先天淋巴细胞 3(NCR- ILC3)、iNKT17 细胞和 IgA2 B 细胞的 TH17 免疫。对于内寄生虫(蠕虫),可消除的宿主免疫途径是涉及炎症性嗜酸性粒细胞(iEOS)、白细胞介素 5/白细胞介素 4(IL-5/IL-4)CD4 T 细胞、白细胞介素 25 诱导的炎症性先天淋巴细胞 2(iILC2)、类胰蛋白酶阳性肥大细胞(MCt)、iNKT2 细胞和 IgG4 B 细胞的 TH2a 免疫。对于外寄生虫(寄生昆虫和蛛形纲动物),可消除的宿主免疫途径是涉及炎症性嗜碱性粒细胞、类胰蛋白酶和类胰蛋白酶阳性肥大细胞(MCct)、白细胞介素 3/白细胞介素 4(IL-3/IL-4)CD4 T 细胞、白细胞介素 33 诱导的先天淋巴细胞 2(nILC2)、iNKT2 细胞和免疫球蛋白 E(IgE)B 细胞的 TH2b 免疫。对于外寄生虫和内寄生虫的可耐受宿主免疫是涉及调节性嗜酸性粒细胞、调节性嗜碱性粒细胞、白细胞介素 9(IL-9)肥大细胞(MMC9)、胸腺基质淋巴细胞生成素诱导的先天淋巴细胞 2、白细胞介素 9(IL-9)CD4 T 细胞、iNKT2 细胞和 IgA2 B 细胞的 TH9 免疫。此外,还列出了与特定免疫反应相关的特定转录因子。JAK/STAT 信号通路是控制或诱导不同免疫途径的关键。总之,Tfh 与 STAT5β 和 BCL6 表达有关。Treg 与 STAT5α、STAT5β 和 FOXP3 有关。TH1 免疫与 STAT1α、STAT4 和 T-bet 有关。TH2a 免疫与 STAT6、STAT1α、GATA1 和 GATA3 有关。TH2b 免疫与 STAT6、STAT3、GATA2 和 GATA3 有关。TH22 免疫与 STAT3α 和 AHR 有关。THαβ 免疫与 STAT1α、STAT1β、STAT2、STAT3β 和 ISGF 有关。TH1 样免疫与 STAT1α、STAT4、STAT5α 和 STAT5β 有关。TH9 免疫与 STAT6、STAT5α、STAT5β 和 PU.1 有关。TH17 免疫与 STAT3α、STAT5α、STAT5β 和 RORG 有关。TH3 免疫与 STAT1α、STAT1β、STAT2、STAT3β、STAT5α、STAT5β 和 ISGF 有关。这种分类为针对四种类型寄生虫感染的免疫途径提供了一个完整的框架。这个框架以及相关的 JAK/STAT 信号通路可以为未来通过疫苗或药物控制过敏反应和寄生虫感染提供有用的知识。